Does Vitamin D supplementation improve function and quality of life in older heart failure patients - A double blind, placebo controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2004-002116-28-GB

Enrollment

136

Registered

2005-03-01

Start date

2005-03-29

Completion date

Unknown

Last updated

2017-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Interventions

Trade Name: Ergocalciferol Product Name: Ergocalciferol Pharmaceutical Form: Capsule* Pharmaceutical form of the placebo: Capsule* Route of administration of the placebo: Oral use

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Left ventricular systolic dysfunction; Age 65 years or over; Vitamin D level =65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: High or low calcium levels; wheelchair bound; metastatic malignancy; already taking Vitamin D

Design outcomes

Primary

Measure	Time frame
Main Objective: Improvement in exercise capacity;Secondary Objective: Improvement in quality of life and everyday activity;Primary end point(s): Six minute walk distance	—

Countries

United Kingdom

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026